These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 16513871

  • 41. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J, Arango C, Garcia-Garcia M, Rejas J, CLAMORS Study Collaborative Group.
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD, Rabinowitz J, Eerdekens M, Davidson M.
    Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J, López-Carrilero R, Iniesta R, Roca M, Caballero M, Rodriguez-Jimenez R, Oliveira C, Bernardo M, Corripio I, Sindreu SD, González Piqueras JC, Felipe AE, Fernandez de Corres B, Ibáñez A, Huerta R, Abordaje Síntomas Negativos Esquizofrenia Group.
    J Clin Psychiatry; 2014 Jun; 75(6):608-15. PubMed ID: 25004184
    [Abstract] [Full Text] [Related]

  • 46. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM, Nepal MK, Koirala NR, Sharma VD, Gurung CK, Adhikari SR.
    Kathmandu Univ Med J (KUMJ); 2006 Jun; 4(2):152-60. PubMed ID: 18603890
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
    Kane JM, Potkin SG, Daniel DG, Buckley PF.
    J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
    [Abstract] [Full Text] [Related]

  • 50. Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety.
    Davies A, Adena MA, Keks NA, Catts SV, Lambert T, Schweitzer I.
    Clin Ther; 1998 Feb; 20(1):58-71. PubMed ID: 9522104
    [Abstract] [Full Text] [Related]

  • 51. Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.
    Khodaie-Ardakani MR, Seddighi S, Modabbernia A, Rezaei F, Salehi B, Ashrafi M, Shams-Alizadeh N, Mohammad-Karimi M, Esfandiari GR, Hajiaghaee R, Akhondzadeh S.
    J Psychiatr Res; 2013 Apr; 47(4):472-8. PubMed ID: 23375406
    [Abstract] [Full Text] [Related]

  • 52. A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia.
    Haas M, Unis AS, Armenteros J, Copenhaver MD, Quiroz JA, Kushner SF.
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):611-21. PubMed ID: 20035579
    [Abstract] [Full Text] [Related]

  • 53. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.
    Devanand DP, Marder K, Michaels KS, Sackeim HA, Bell K, Sullivan MA, Cooper TB, Pelton GH, Mayeux R.
    Am J Psychiatry; 1998 Nov; 155(11):1512-20. PubMed ID: 9812111
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW, Wirshing DA, Safferman A, Ganguli R, McMeniman M, Borenstein M.
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.
    Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.
    Int Clin Psychopharmacol; 2001 Nov; 16(6):325-30. PubMed ID: 11712620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.